Psychotropic Medication and Psychosocial Service Use Among Transition Age Youth With Autism Spectrum Disorder.
Am J Intellect Dev Disabil
; 129(1): 1-9, 2024 Jan 01.
Article
em En
| MEDLINE
| ID: mdl-38147886
ABSTRACT
People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transtorno do Espectro Autista
Limite:
Adolescent
/
Humans
Idioma:
En
Revista:
Am J Intellect Dev Disabil
Assunto da revista:
TRANSTORNOS MENTAIS
Ano de publicação:
2024
Tipo de documento:
Article